PROTAC BCR-ABL Degrader-1 (compound PROTAC 1), featuring a 2-oxoethyl linker, induces Bcr-Abl degradation via the ubiquitin-proteasome pathway and exhibits antiproliferative effects on K562 cells, indicating its potential in cancer research [1].
Molecular Weight:
792.84
Formula:
C43H40N10O6
Target:
Bcr-Abl|||PROTACs
* VAT and and shipping costs not included. Errors and price changes excepted
